AUTOPERFUSION BALLOON VERSUS STENT FOR ACUTE OR THREATENED CLOSURE DURING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY

Citation
Ed. Demuinck et al., AUTOPERFUSION BALLOON VERSUS STENT FOR ACUTE OR THREATENED CLOSURE DURING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY, The American journal of cardiology, 74(10), 1994, pp. 1002-1005
Citations number
20
Categorie Soggetti
Cardiac & Cardiovascular System
ISSN journal
00029149
Volume
74
Issue
10
Year of publication
1994
Pages
1002 - 1005
Database
ISI
SICI code
0002-9149(1994)74:10<1002:ABVSFA>2.0.ZU;2-L
Abstract
Efficacy and major clinical end points were compared in 61 patients tr eated with a Stack autoperfusion balloon versus 36 patients who receiv ed a Palmaz-Schatz stent for acute or threatened closure during corona ry angioplasty. The groups were comparable regarding baseline clinical characteristics. Procedural success was achieved in 43 patients (70%) treated with an autoperfusion balloon versus 34 patients (94%) who re ceived a stent (p <0.02). Emergency bypass surgery was performed in 13 patients (21%) with the autoperfusion balloon versus none of the pati ents with a stent (p <0.001). in the stent group; 3 patients (8%) died (p <0.05); 2 deaths were caused by thrombotic reclosure, and 1 patien t died after unsuccessful stent delivery. Subacute reclosure during ho spitalization occurred in none of the patients with autoperfusion vers us 8 patients with the stent (22%) (p <0.0002). Therefore, the number of patients with successful stent implantation at discharge decreased to 26 (72%). At 3-month follow-up in all patients;with a successful in tervention, reclosure or angiographic restenosis (>50%) occurred in 13 patients with autoperfusion (30%) versus 3 patients with stents (12%) (p = NS). There was no difference in event-free survival during follo w-up. Thus, both interventions were equally successful in the treatmen t of acute and threatened closure. More emergency surgery was performe d in the autoperfusion balloon group, whereas a higher subacute reclos ure rate was seen in the stent group. At 3-month follow-up, there were no significant differences regarding reclosure, restenosis, and event -free survival.